# Atorvastatin and Endothelial Function in Type 2 Diabetes Mellitus (ATTEND-Study)

> **NCT00124397** · PHASE4 · COMPLETED · sponsor: **University of Southern Denmark** · enrollment: 186 (—)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** Atorvastatin

## Key facts

- **NCT ID:** NCT00124397
- **Lead sponsor:** University of Southern Denmark
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-07
- **Primary completion:** —
- **Final completion:** 2004-12
- **Target enrollment:** 186 (—)
- **Last updated:** 2005-08-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00124397

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00124397, "Atorvastatin and Endothelial Function in Type 2 Diabetes Mellitus (ATTEND-Study)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00124397. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*